🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

52+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 12 of 52 recruiting trials for “Duchenne muscular dystrophy”

RecruitingNCT05683379 ↗

AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Males With DMD

🏥 REGENXBIO Inc.📍 1 site📅 Started Dec 2022View details ↗
NARecruitingNCT06366815 ↗

phenotypeS in Non Ambulant Duchenne Muscular Dystrophy

👨‍⚕️ Marika Pane, Fondazione Policlinico Universitario A. Gemelli, IRCCS📍 2 sites📅 Started Aug 2022View details ↗
Phase 1RecruitingNCT04906460 ↗

Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

👨‍⚕️ Medical Director, MD, Wave Life Sciences📍 5 sites📅 Started Sep 2021View details ↗
NARecruitingNCT04972604 ↗

CureDuchenne Link®: A Resource for Research

👨‍⚕️ Debra Miller, CureDuchenne📍 10 sites📅 Started Jul 2021View details ↗
Phase 4RecruitingNCT05412394 ↗

Once Weekly Infant Corticosteroid Trial for DMD

👨‍⚕️ Anne Connolly, MD, Nationwide Children's Hospital📍 4 sites📅 Started Apr 2021View details ↗
NARecruitingNCT01484678 ↗

Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy

👨‍⚕️ William Rooney, PhD, Oregan Health and Science University📍 3 sites📅 Started Sep 2020View details ↗
NARecruitingNCT05982119 ↗

Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study

🏥 Centre Hospitalier Universitaire de Liege📍 8 sites📅 Started Jul 2020View details ↗
NARecruitingNCT03882827 ↗

Natural History of Duchenne Muscular Dystrophy

👨‍⚕️ Francesco MUNTONI, Pr, GOSH LONDON📍 15 sites📅 Started Dec 2019View details ↗
RecruitingNCT05016908 ↗

Extracellular RNA Biomarkers of Duchenne Muscular Dystrophy

👨‍⚕️ Thurman M. Wheeler, MD, Massachusetts General Hospital📍 2 sites📅 Started Nov 2019View details ↗
RecruitingNCT04012671 ↗

A Registered Cohort Study on Duchenne Muscular Dystrophy

🏥 Ning Wang, MD., PhD.📍 1 site📅 Started Jul 2019View details ↗
NAEnrolling by InvitationNCT06606340 ↗

A Long-term Observational Study Evaluating Eteplirsen, Golodirsen, or Casimersen in Routine Clinical Practice

🏥 Sarepta Therapeutics, Inc.📍 20 sites📅 Started Jan 2019View details ↗
Phase 2, PHASE3RecruitingNCT03373968 ↗

Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study

🏥 Italfarmaco📍 39 sites📅 Started Oct 2017View details ↗
← PreviousPage 3 of 3

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →